Tattoos and Risk of Hematologic Cancer: A Population-Based Case-Control Study in Utah.

Autor: McCarty RD; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Department of Population Health Sciences Spencer Fox Eccles School of Medicine, University of Utah Intermountain Healthcare, University of Utah, Salt Lake City, Utah, USA., Trabert B; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Department of Obstetrics and Gynecology, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, Utah, USA., Kriebel D; Lowell Center for Sustainable Production, University of Massachusetts Lowell, Lowell, Massachusetts, USA., Millar MM; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA.; Utah Cancer Registry, University of Utah, Salt Lake City, Utah, USA., Birmann BM; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA., Grieshober L; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Department of Population Health Sciences Spencer Fox Eccles School of Medicine, University of Utah Intermountain Healthcare, University of Utah, Salt Lake City, Utah, USA., Barnard ME; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Department of Population Health Sciences Spencer Fox Eccles School of Medicine, University of Utah Intermountain Healthcare, University of Utah, Salt Lake City, Utah, USA.; Slone Epidemiology Center, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts, USA., Collin LJ; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Department of Population Health Sciences Spencer Fox Eccles School of Medicine, University of Utah Intermountain Healthcare, University of Utah, Salt Lake City, Utah, USA., Lawson-Michod KA; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Department of Population Health Sciences Spencer Fox Eccles School of Medicine, University of Utah Intermountain Healthcare, University of Utah, Salt Lake City, Utah, USA., Gibson B; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Department of Population Health Sciences Spencer Fox Eccles School of Medicine, University of Utah Intermountain Healthcare, University of Utah, Salt Lake City, Utah, USA., Sawatzki J; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA., Carter M; Utah Cancer Registry, University of Utah, Salt Lake City, Utah, USA., Yoder V; Utah Cancer Registry, University of Utah, Salt Lake City, Utah, USA., Gilreath JA; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA., Shami PJ; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA., Doherty JA; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.

Publikováno v: Cancer medicine [Cancer Med] 2024 Oct; Vol. 13 (20), pp. e70260.

Associations of demographic, health, and risk-taking behaviors with tattooing in a population-based cross-sectional study of ~18,000 US adults.

Autor: McCarty RD; Huntsman Cancer Institute., Trabert B; Huntsman Cancer Institute., Millar MM; Huntsman Cancer Institute., Kriebel D; University of Massachusetts Lowell., Grieshober L; Huntsman Cancer Institute., Barnard ME; Boston University., Collin LJ; Huntsman Cancer Institute., Lawson-Michod KA; Huntsman Cancer Institute., Gibson B; Huntsman Cancer Institute., Gilreath JA; Huntsman Cancer Institute., Shami PJ; Huntsman Cancer Institute., Doherty JA; Huntsman Cancer Institute.

Publikováno v: Research square [Res Sq] 2024 Aug 28. Date of Electronic Publication: 2024 Aug 28.

Impact of metformin on tyrosine kinase inhibitor response in chronic myeloid leukemia.

Autor: Pokorny R; Department of Pharmacy, 20270Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Stenehjem DD; Department of Pharmacy Practice and Pharmaceutical Sciences, 14713University of Minnesota, College of Pharmacy, Duluth, MN, USA., Gilreath JA; Department of Pharmacotherapy, College of Pharmacy and 20270Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.

Publikováno v: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2022 Jun; Vol. 28 (4), pp. 916-923. Date of Electronic Publication: 2022 Feb 08.

Daratumumab as a novel treatment for refractory acquired von Willebrand syndrome associated with monoclonal gammopathy.

Autor: Mathew Thomas V; Department of Internal Medicine, University of Connecticut, Farmington, CT, USA., Gilreath JA; Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City, UT, USA.; Department of Pharmacy Services, University of Utah Huntsman Cancer Hospital, Salt Lake City, UT, USA., Newton S; Department of Pharmacy Services, University of Utah Huntsman Cancer Hospital, Salt Lake City, UT, USA., Smock KJ; Department of Pathology, University of Utah and ARUP Laboratories, Salt Lake City, UT, USA., Lim MY; Division of Hematology and Hematologic Malignancies, Department of Internal Medicine, University of Utah, Salt Lake City, UT, USA.

Publikováno v: Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2021 Jul; Vol. 27 (4), pp. e563-e566. Date of Electronic Publication: 2021 Apr 28.

How I treat cancer-associated anemia.

Autor: Gilreath JA; Department of Pharmacotherapy, University of Utah College of Pharmacy, and., Rodgers GM; Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute at University of Utah, Salt Lake City, UT.

Publikováno v: Blood [Blood] 2020 Aug 13; Vol. 136 (7), pp. 801-813.